Health ❯Medicine ❯Pharmacology

Weight Loss

GLP-1 Receptor Agonists Obesity Treatment Experimental Drugs Weight Loss Drugs GLP-1 Agonists GLP-1 Medications Semaglutide Weight Loss Injections Tridecaneuropeptide (TDN) Wegovy Anti-Obesity Medications Tirzepatide Weight-Loss Injections Obesity Medications GLP-1 Drugs

Astrocyte-Derived Peptide Achieves Nausea-Free Weight Loss in Animal Models

CoronationBio plans human trials in 2026 after TDN injections suppressed appetite in animals without causing nausea

Experimental ODN-Derived Drug Curbs Appetite Without Nausea

Experimental Drug SANA Boosts Fat Thermogenesis to Promote Weight Loss Ahead of Phase 2 Trials

Novo Nordisk’s Amycretin Achieves Up to 24% Weight Loss as It Advances to Phase 3

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

UK Nears One Million Users of Weight-Loss Jabs as New Benefits and Risks Emerge

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

Experts Explore Potential of Ozempic Microdosing for Health Beyond Weight Loss

Semaglutide Shows Promising Results in Reducing Knee Arthritis Pain in Obese Patients